Characterization of a novel microfluidic platform for the isolation of rare single cells to enable CTC analysis from head and neck squamous cell carcinoma patients

Detailed examination of tumor components is leading‐edge to establish personalized cancer therapy. Accompanying research on cell‐free DNA, the cell count of circulating tumor cells (CTCs) in patient blood is seen as a crucial prognostic factor. The potential of CTC analysis is further not limited to...

Descripción completa

Detalles Bibliográficos
Autores principales: Stiefel, Janis, Freese, Christian, Sriram, Ashwin, Alebrand, Sabine, Srinivas, Nalini, Sproll, Christoph, Wandrey, Madita, Gül, Désirée, Hagemann, Jan, Becker, Jürgen C., Baßler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077830/
https://www.ncbi.nlm.nih.gov/pubmed/35573135
http://dx.doi.org/10.1002/elsc.202100133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077830/
https://www.ncbi.nlm.nih.gov/pubmed/35573135
http://dx.doi.org/10.1002/elsc.202100133

Ejemplares similares